Search for: "Bui v. State" Results 2101 - 2120 of 9,822
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2019, 1:43 pm by Jason Wong
The Board did not buy the Employer’s argument that the termination was solely due to business reasons – failing to acquire the new building. [read post]
27 Mar 2019, 1:00 am by Thaddeus Mason Pope, JD, PhD
Health Reform Erin Fuse Brown, Georgia State University College of Law, Could States Do Single-Payer? [read post]
24 Mar 2019, 5:08 pm by INFORRM
Butt v Secretary of State for the Home Department, heard 17 October 2018 (Underhill V-P, Sharp LJ and Sir Rupert Jackson). [read post]
24 Mar 2019, 8:46 am by Dan Harris
More importantly, I need to go watch the Washington Huskies v. [read post]
22 Mar 2019, 9:00 am by Staff
The Anti-Kickback Statute (AKS) forbids physicians from knowingly and willfully soliciting, paying, offering, or accepting remuneration to: Refer a patient for services or any item for which the payment for that service or item is made (in whole or in part) by a Federal health care agency or Buying, ordering, leasing (or recommending buying, ordering, or leasing) any service, good, or facility (in whole or in part) for which payment for that service, good, or facility is made by a… [read post]
21 Mar 2019, 3:04 pm by Giles Peaker
Golding v Martin (2019) EWCA Civ 446 It seems to be a bit of a thing, buying a leasehold flat, then leaving it unoccupied, moving abroad and forgetting about rent and service charges. [read post]
17 Mar 2019, 1:55 pm by John Floyd
The Supreme Court effectively redefined the concept in 1922 in United States v. [read post]
16 Mar 2019, 11:15 am by Larry
That is the issue in McMesson Canada Corp. v. [read post]
15 Mar 2019, 9:00 am by Staff
Subsequent to the FDA approval of Epidiolox, The Drug Enforcement Administration (DEA) issued a Final Order placing “FDA-approved drugs that contain CBD derived from cannabis and no more than 0.1 percent tetrahydrocannabinols” [such as Epidiolox] in Schedule V of the Controlled Substances Act,”  “Schedule V drugs are considered to have the lowest potential for abuse compared to other scheduled drugs and a low potential for psychological or physical… [read post]